Prostatic Neoplasms, Castration-Resistant Active Not Recruiting Phase 1 Trials for Apalutamide (DB11901)

IndicationStatusPhase
DBCOND0001230 (Prostatic Neoplasms, Castration-Resistant)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02162836A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate CancerTreatment
NCT02592317A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate CancerTreatment